Literature DB >> 17003232

Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.

Naoyuki Matsuda1, Yukio Hayashi, Yoshika Takahashi, Yuichi Hattori.   

Abstract

Endothelial dysfunction plays a crucial role in the pathophysiology of sepsis. Alterations in endothelial nitric-oxide synthase (eNOS) may contribute to the impaired endothelial function. We investigated whether the regulatory mechanism for eNOS phosphorylation and activation is altered in a rabbit lipopolysaccharide-induced septic model. Following induction of sepsis, a time-dependent marked reduction in eNOS phosphorylation was observed in mesenteric arteries, with a significant decrease in eNOS expression. Likewise, Akt phosphorylation was progressively and profoundly reduced, although total Akt remained unchanged. Furthermore, the amounts of the two subunits of phosphatidylinositol 3-kinase (PI3-K) in the membranous pool were diminished without changes in the total amount of the PI3-K heterodimer, indicating a decrease in translocation to the membranes. In vivo treatment with fluvastatin restored the decrease in eNOS phosphorylation in septic mesenteric vessels. This was possibly the result of the recovery of Akt phosphorylation. Treatment with the PI3-K inhibitor wortmannin partially inhibited the fluvastatin-induced increases in phosphorylation of Akt and eNOS, and the decrease in translocation of PI3-K heterodimer to the membranes during sepsis was slightly improved by fluvastatin. Sepsis-induced impairment of eNOS expression was also nearly normalized by fluvastatin. It is noteworthy that rabbits treated with fluvastatin exhibited a dramatic improvement in sepsis survival. The present results showed vascular abnormalities of the PI3-K/Akt pathway involved in the impairment of eNOS phosphorylation and activation in sepsis. We also suggest that fluvastatin would ameliorate vascular endothelial dysfunction, in part, presumably via its recovery effect on Akt-dependent eNOS phosphorylation. It may be potentially useful for therapy of sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003232     DOI: 10.1124/jpet.106.109785

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

Review 1.  Statins for community-acquired pneumonia: current state of the science.

Authors:  D Viasus; C Garcia-Vidal; F Gudiol; J Carratalà
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-27       Impact factor: 3.267

2.  Resveratrol Prevented Lipopolysaccharide-Induced Endothelial Dysfunction in Rat Thoracic Aorta Through Increased eNOS Expression.

Authors:  Seda Sultan Uğurel; Nilay Kuşçu; Çiler Çelik Özenci; Selvinaz Dalaklıoğlu; Arda Taşatargil
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

3.  Role of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs.

Authors:  Yuta Aoki; Noboru Hatakeyama; Seiji Yamamoto; Hiroyuki Kinoshita; Naoyuki Matsuda; Yuichi Hattori; Mitsuaki Yamazaki
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Endothelial nitric oxide synthase in the microcirculation.

Authors:  Xiaohong Shu; T C Stevenson Keller; Daniela Begandt; Joshua T Butcher; Lauren Biwer; Alexander S Keller; Linda Columbus; Brant E Isakson
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

5.  Role of ghrelin-induced phosphatidylinositol 3-kinase activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2013-09-21       Impact factor: 4.473

6.  Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock.

Authors:  Youcef Bouazza; Nacira Sennoun; Charlène Strub; Véronique Regnault; Sebastien Gibot; Ferhat Meziani; Patrick Lacolley; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-08-18       Impact factor: 17.440

7.  Beneficial effect of the oligomerized polyphenol oligonol on high glucose-induced changes in eNOS phosphorylation and dephosphorylation in endothelial cells.

Authors:  Xiao-Hong Zhang; Hiroki Yokoo; Hiroshi Nishioka; Hajime Fujii; Naoyuki Matsuda; Toshio Hayashi; Yuichi Hattori
Journal:  Br J Pharmacol       Date:  2010-01-29       Impact factor: 8.739

8.  Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII.

Authors:  Caroline C McGown; Zoë L S Brookes; Paul G Hellewell; Jonathan J Ross; Nicola J Brown
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-14       Impact factor: 3.000

9.  Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  Wei-Jian Zhang; Hao Wei; Tory Hagen; Balz Frei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

10.  Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.

Authors:  Charalambos Antoniades; Constantinos Bakogiannis; Paul Leeson; Tomasz J Guzik; Mei-Hua Zhang; Dimitris Tousoulis; Alexios S Antonopoulos; Michael Demosthenous; Kyriakoula Marinou; Ashley Hale; Andreas Paschalis; Costas Psarros; Costas Triantafyllou; Jennifer Bendall; Barbara Casadei; Christodoulos Stefanadis; Keith M Channon
Journal:  Circulation       Date:  2011-07-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.